Adenoma Colon Polyp Clinical Trial
Official title:
LCI (Linked Color Imaging) for Adenoma Detection in the Right Colon
Verified date | September 2017 |
Source | Valduce Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Although colonoscopy with polypectomy can prevent up to 80% of colorectal cancers, a
significant adenoma miss rate still exists, particularly in the right colon. Optimizing the
detection of adenomas and sessile serrated lesions in the right colon is crucial to increase
the effectiveness of colonoscopy in colorectal cancer prevention.
Last generation Fuji videocolonscopes incorporates the Linked Color Imaging (LCI), a recently
developed technology that differentiates the red colour spectrum more effectively than White
Light imaging thanks to its optimal pre-process composition of light spectrum and advanced
signal processing. The increased colour contrast results in more accurate delineation of
abnormal inflammatory or neoplastic findings of colonic mucosa. Preliminary data suggest that
LCI may be improve the detection of neoplastic lesion of colon.
The investigators performe a tandem prospective study to compare the right colon adenoma miss
rates of LCI colonoscopy with those of conventional white light colonoscopy.
Therefore participants scheduled for colonoscopy for the assessment of symptoms or for
colorectal cancer screening/surveillance receive the examination of the right colon twice, in
a back to back fashion, with standard white light (WL) and with LCI. Patients are randomly
assigned (1:1), via computer-generated randomisation with block size of 20, to which
procedure is done first. The endoscopist are masked to group allocation until immediately
before the cecum is reached. Examinations are performed with Fuji videocolonscopes series 700
(EC-760R, EC-760ZP).
Status | Recruiting |
Enrollment | 752 |
Est. completion date | December 30, 2017 |
Est. primary completion date | December 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - all outpatients referred for colonoscopy Exclusion Criteria: - inadequatete bowel preparation (Boston Bowel Preparation Scale (BBPS) < 2 in one colonic segment) - previous colonic resection - inflammatory bowel disease - ereditary polyposic syndromes - patients on antithrombotics precluding polyp recetion - absence of informed consent - inpatients or patients undergoing urgent colonscopy |
Country | Name | City | State |
---|---|---|---|
Italy | Gastroenterology Unit, Valduce Hospital | Como |
Lead Sponsor | Collaborator |
---|---|
Valduce Hospital |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Right colon adenoma miss rate | Number of adenomas identified during the second right coloninspection/ overall number of adenomas identified during the first and the second right colon inspection | One year | |
Secondary | Right colon advanced adenomas (size>1 cm and/or high grade displasia and/or villous component) miss rate | Number of advanced adenomas identified during the second right coloninspection/ overall number of advanced adenomas identified during the first and the second right colon inspection | One year | |
Secondary | Right colon sessile serrated lesions miss rate | Number of sessile serrated lesions identified during the second right coloninspection/ overall number of sessile serrated lesions identified during the first and the second right colon inspection | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06406062 -
Artificial Intelligence-assisted System in Colonoscopy
|
||
Completed |
NCT03775811 -
In Vivo Computer-aided Prediction of Polyp Histology on White Light Colonoscopy
|